Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma by Yu-Qin Song, Hui-Lai Zhang, Hui-Qiang Huang, Qing-Yuan Zhang, Hong-Mei Jing, Chao Wang, Chun Wu, Dong-Hang Li, Yu Dai, Kathryn Humphrey, Jun Zhu

Get full text